WallStreetZenWallStreetZen

NYSE: LH
LABORATORY CORP OF AMERICA HOLDINGS Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

LH past earnings growth

How has LH's earnings growth performed historically?
Company
-18.95%
Industry
19.84%
Market
87.2%
LH's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
LH's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
LH's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

LH past revenue growth

How has LH's revenue growth performed historically?
Company
3.54%
Industry
20.73%
Market
49.25%
LH's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
LH's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
LH's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

LH earnings and revenue history

Current Revenue
$15.9B
Current Earnings
$2.1B
Current Profit Margin
13.2%
LH's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

LH Return on Equity

Current Company
20.1%
Current Industry
39.7%
Current Market
38.4%
LH's Return on Equity (20.1%)... subscribe to Premium to read more.
High Return on Equity Performance

LH Return on Assets

Current Company
10.2%
Current Industry
8.4%
LH is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

LH Return on Capital Employed

Current Company
16.3%
Current Industry
13.2%
LH has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LH vs Diagnostics & Research Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
LH$15.86B$3.87B$2.10B+10.56%+25.32%
PHG$19.50B$5.37B$3.77B+1.23%+20.18%
WAT$2.87B$997.14M$704.55M+5.54%+11.70%
MTD$3.81B$1.13B$793.32M+8.26%+17.16%
PKI$5.02B$1.53B$740.81M+18.68%+24.53%
View Top Diagnostics & Research Stocks

LABORATORY OF AMERICA HOLDINGS Earnings & Revenue FAQ

What were LH's earnings last quarter?

On Invalid Date, LABORATORY OF AMERICA HOLDINGS (NYSE: LH) reported Q1 2022 earnings per share (EPS) of $5.27, up 33.12% year over year. Total LABORATORY OF AMERICA HOLDINGS earnings for the quarter were $491.60 million. In the same quarter last year, LABORATORY OF AMERICA HOLDINGS's earnings per share (EPS) was $7.88.

What was LH's earnings growth in the past year?

As of Q2 2022, LABORATORY OF AMERICA HOLDINGS's earnings has grown -18.95% year over year. This is 38.79 percentage points lower than the US Diagnostics & Research industry earnings growth rate of 19.84%. LABORATORY OF AMERICA HOLDINGS's earnings in the past year totalled $2.10 billion.

What was LH's revenue last quarter?

On Invalid Date, LABORATORY OF AMERICA HOLDINGS (NYSE: LH) reported Q1 2022 revenue of $3.90 billion up 6.29% year over year. In the same quarter last year, LABORATORY OF AMERICA HOLDINGS's revenue was $4.16 billion.

What was LH's revenue growth in the past year?

As of Q2 2022, LABORATORY OF AMERICA HOLDINGS's revenue has grown 3.54% year over year. This is 17.18 percentage points lower than the US Diagnostics & Research industry revenue growth rate of 20.73%. LABORATORY OF AMERICA HOLDINGS's revenue in the past year totalled $15.86 billion.
©2022 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending StocksStock Market SectorsStock Market Industries
Analysts
Top Performing Analysts
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.